← Back
Data updated: Mar 10, 2026
NANJING KING FRIEND
CardiovascularMetabolic
NANJING KING FRIEND is a generic drug manufacturer focused on Cardiovascular, Metabolic.
2025
Since
3
Drugs
-
Trials
22
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LIRAGLUTIDE 2026-02-24
LIRAGLUTIDE 2026-02-24
LIRAGLUTIDE 2026-01-14
NICARDIPINE HYDROCHLORIDE 2025-12-18
Manufacturing (CMC)
PROPOFOL 2025-12-02
NICARDIPINE HYDROCHLORIDE 2025-10-28
LIRAGLUTIDE 2025-10-15
Labeling
PROPOFOL 2025-09-19
Labeling
LIRAGLUTIDE 2025-08-27
NICARDIPINE HYDROCHLORIDE 2025-08-20
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Cardiovascular 50%
1 drugs
Metabolic 50%
1 drugs
Pipeline Strength Pro
Loading...
Active (3)
Discontinued (0)
Company Info
- First Approval
- 2025-04-02
- Latest
- 2025-12-02
- Applications
- 3